Home >> Research Area >>Microbiology and Virology>>CMV>> Valganciclovir HCl

Valganciclovir HCl

CAS# 175865-59-5

Valganciclovir HCl

Catalog No. BCC4745----Order now to get a substantial discount!

Product Name & Size Price Stock
Valganciclovir HCl:50mg $104.00 In stock
Valganciclovir HCl:100mg $177.00 In stock
Valganciclovir HCl:250mg $416.00 In stock
Valganciclovir HCl:500mg $728.00 In stock
Related Products

Quality Control of Valganciclovir HCl

Number of papers citing our products

Chemical structure

Valganciclovir HCl

3D structure

Chemical Properties of Valganciclovir HCl

Cas No. 175865-59-5 SDF Download SDF
PubChem ID 135413534 Appearance Powder
Formula C14H23ClN6O5 M.Wt 390.82
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : 50 mg/mL (127.94 mM; Need ultrasonic)
H2O : ≥ 50 mg/mL (127.94 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name [2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate;hydrochloride
SMILES [Cl-].CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2C(=O)N=C(N)Nc12.[H+]
Standard InChIKey ZORWARFPXPVJLW-MTFPJWTKSA-N
Standard InChI InChI=1S/C14H22N6O5.ClH/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22;/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22);1H/t8?,9-;/m0./s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of Valganciclovir HCl

DescriptionValganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections. IC50 Value: Target: CMV in vitro: In cell culture model systems using Caco-2 cells for PEPT1 and SKPT cells for PEPT2, valganciclovir inhibited glycylsarcosine transport mediated by PEPT1 and PEPT2 with K(i) values (inhibition constant) of 1.68+/-0.30 and 0.043+/- 0.005 mM, respectively. The inhibition by valganciclovir was competitive in both cases [1]. in vivo: 37 patients were enrolled; 19 patients received treatment with VGV and 18 patients received treatment with GCV. The VGV was not inferior in efficacy to GCV as pre-emptive therapy, with rates of viral clearance at 28 days of 89.5% and 83%, respectively (P-value for non-inferiority = 0.030). Toxicities were similar between the 2 arms. No patients developed CMV disease [2]. Patients being treated with an alemtuzumab-containing regimen received prophylaxis with either valaciclovir 500 mg orally daily orvalganciclovir 450 mg orally twice daily. None of the 20 patients randomized to valganciclovir experienced CMV reactivation (P = .004) [3].

References:
[1]. Sugawara M, et al. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci. 2000 Jun;89(6):781-9. [2]. Chawla JS, et al. Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature. Transpl Infect Dis. 2012 Jun;14(3):259-67. [3]. O'Brien S, et al. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood. 2008 Feb 15;111(4):1816-9.

Valganciclovir HCl Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Valganciclovir HCl Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Valganciclovir HCl

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.5587 mL 12.7936 mL 25.5872 mL 51.1745 mL 63.9681 mL
5 mM 0.5117 mL 2.5587 mL 5.1174 mL 10.2349 mL 12.7936 mL
10 mM 0.2559 mL 1.2794 mL 2.5587 mL 5.1174 mL 6.3968 mL
50 mM 0.0512 mL 0.2559 mL 0.5117 mL 1.0235 mL 1.2794 mL
100 mM 0.0256 mL 0.1279 mL 0.2559 mL 0.5117 mL 0.6397 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Valganciclovir HCl

Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.

Featured Products
New Products
 

Description

Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir.

Keywords:

Valganciclovir HCl,175865-59-5,Natural Products,CMV, buy Valganciclovir HCl , Valganciclovir HCl supplier , purchase Valganciclovir HCl , Valganciclovir HCl cost , Valganciclovir HCl manufacturer , order Valganciclovir HCl , high purity Valganciclovir HCl

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: